Fresenius Medical Care AG & Co. KGaA (1FME) Stock Forecast & Price Target

Compare

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

1FME Analyst Ratings

Hold

2 Buy

5 Hold

5 Sell

Based on 12 analysts giving stock ratings to

Fresenius

Medical Care AG & Co. KGaA

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

1FME Stock 12 Month Forecast

Average Price Target

€42.20

▲(6.03% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Fresenius Medical Care AG & Co. KGaA in the last 3 months. The average price target is €42.20 with a high forecast of €60.00 and a low forecast of €32.00. The average price target represents a 6.03% change from the last price of €39.80.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"31":"€31","46":"€46","61":"€61","38.5":"€38.5","53.5":"€53.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":60,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€60.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":42.2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€42.20</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":32,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€32.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[31,38.5,46,53.5,61],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,38.19,39.86769230769231,41.54538461538461,43.223076923076924,44.90076923076923,46.57846153846154,48.25615384615384,49.933846153846154,51.61153846153846,53.28923076923077,54.96692307692308,56.644615384615385,58.32230769230769,{"y":60,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,38.19,38.498461538461534,38.80692307692308,39.11538461538461,39.423846153846156,39.73230769230769,40.04076923076923,40.34923076923077,40.65769230769231,40.966153846153844,41.27461538461539,41.58307692307692,41.89153846153847,{"y":42.2,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,38.19,37.71384615384615,37.237692307692306,36.76153846153846,36.285384615384615,35.809230769230766,35.33307692307692,34.856923076923074,34.38076923076923,33.90461538461538,33.42846153846154,32.95230769230769,32.47615384615385,{"y":32,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":46.814,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 12</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":45.025,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 11</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":44.636,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":43.108,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":50.38,"date":1748736000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 11</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":48.63,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":43.32,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 8</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":43.88,"date":1756684800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 8</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":45.19,"date":1759276800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 11</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":46.64,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 12</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":40.97,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":39.98,"date":1767225600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":38.19,"date":1769904000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 11</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€60.00

Average Price Target€42.20

Lowest Price Target€32.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Graham Doyle

UBS

€38

Sell

-4.52%

Downside

Reiterated

02/10/26

UBS Remains a Sell on Fresenius Medical Care AG & Co. KGaA (0H9X)

Hassan Al-Wakeel

Barclays

€47.5

Hold

19.35%

Upside

Reiterated

02/03/26

Barclays Sticks to Their Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

James Vane

Jefferies

€36

Sell

-9.55%

Downside

Reiterated

02/02/26

Jefferies Sticks to Their Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Aisyah Noor

Morgan Stanley

€37→€36

Sell

-9.55%

Downside

Reiterated

01/27/26

Fresenius Medical price target lowered to EUR 36 from EUR 37 at Morgan StanleyFresenius Medical price target lowered to EUR 36 from EUR 37 at Morgan Stanley

Anna Ractliffe

Bank of America Securities

€35→€32

Sell

-19.60%

Downside

Reiterated

01/26/26

Weak Operating Momentum, Limited Earnings Visibility, and 2026 Headwinds Drive Underperform (Sell) Rating and Price Target Cut to €32

Falko Friedrichs

Deutsche Bank

€46→€44

Hold

10.55%

Upside

Reiterated

01/26/26

Deutsche Bank Remains a Hold on Fresenius Medical Care AG & Co. KGaA (0H9X)

Veronika Dubajova

Citi

€48.5→€39.5

Hold

-0.75%

Downside

Reiterated

01/23/26

Fresenius Medical price target lowered to EUR 39.50 from EUR 48.50 at CitiFresenius Medical price target lowered to EUR 39.50 from EUR 48.50 at Citi

David Adlington

J.P. Morgan

€37.4

Sell

-6.03%

Downside

Reiterated

01/23/26

J.P. Morgan Sticks to Its Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Oliver Reinberg

Kepler Capital

€49

Hold

23.12%

Upside

Reiterated

01/21/26

Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Hold from Kepler Capital

Richard Felton

Goldman Sachs

€55→€40

Hold

0.50%

Upside

Downgraded

01/20/26

Fresenius Medical Care AG & Co. KGaA (0H9X) was downgraded to a Hold Rating at Goldman Sachs

Harald Hof

mwb research

€46→€47

Buy

18.09%

Upside

Upgraded

01/12/26

Sam England

Berenberg Bank

€60

Buy

50.75%

Upside

Reiterated

12/03/25

Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Buy from Berenberg Bank

Unknown Analyst

DZ BANK AG

Not Ranked

DZ BANK AG

―

Buy

―

Reiterated

11/05/25

Lisa Bedell Clive

Bernstein

€54.5

Hold

36.93%

Upside

Reiterated

10/20/25

Bernstein Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Graham Doyle

UBS

€38

Sell

-4.52%

Downside

Reiterated

02/10/26

UBS Remains a Sell on Fresenius Medical Care AG & Co. KGaA (0H9X)

Hassan Al-Wakeel

Barclays

€47.5

Hold

19.35%

Upside

Reiterated

02/03/26

Barclays Sticks to Their Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

James Vane

Jefferies

€36

Sell

-9.55%

Downside

Reiterated

02/02/26

Jefferies Sticks to Their Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Aisyah Noor

Morgan Stanley

€37→€36

Sell

-9.55%

Downside

Reiterated

01/27/26

Fresenius Medical price target lowered to EUR 36 from EUR 37 at Morgan StanleyFresenius Medical price target lowered to EUR 36 from EUR 37 at Morgan Stanley

Anna Ractliffe

Bank of America Securities

€35→€32

Sell

-19.60%

Downside

Reiterated

01/26/26

Weak Operating Momentum, Limited Earnings Visibility, and 2026 Headwinds Drive Underperform (Sell) Rating and Price Target Cut to €32

Falko Friedrichs

Deutsche Bank

€46→€44

Hold

10.55%

Upside

Reiterated

01/26/26

Deutsche Bank Remains a Hold on Fresenius Medical Care AG & Co. KGaA (0H9X)

Veronika Dubajova

Citi

€48.5→€39.5

Hold

-0.75%

Downside

Reiterated

01/23/26

Fresenius Medical price target lowered to EUR 39.50 from EUR 48.50 at CitiFresenius Medical price target lowered to EUR 39.50 from EUR 48.50 at Citi

David Adlington

J.P. Morgan

€37.4

Sell

-6.03%

Downside

Reiterated

01/23/26

J.P. Morgan Sticks to Its Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Oliver Reinberg

Kepler Capital

€49

Hold

23.12%

Upside

Reiterated

01/21/26

Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Hold from Kepler Capital

Richard Felton

Goldman Sachs

€55→€40

Hold

0.50%

Upside

Downgraded

01/20/26

Fresenius Medical Care AG & Co. KGaA (0H9X) was downgraded to a Hold Rating at Goldman Sachs

Harald Hof

mwb research

€46→€47

Buy

18.09%

Upside

Upgraded

01/12/26

Sam England

Berenberg Bank

€60

Buy

50.75%

Upside

Reiterated

12/03/25

Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Buy from Berenberg Bank

Unknown Analyst

DZ BANK AG

Not Ranked

DZ BANK AG

―

Buy

―

Reiterated

11/05/25

Lisa Bedell Clive

Bernstein

€54.5

Hold

36.93%

Upside

Reiterated

10/20/25

Bernstein Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Fresenius Medical Care AG & Co. KGaA

3 Months

xxx

Success Rate

21/48 ratings generated profit

Average Return

-3.23%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 43.75% of your transactions generating a profit, with an average return of -3.23% per trade.

1 Year

James VaneJefferies

Success Rate

27/48 ratings generated profit

Average Return

-2.20%

a rating ―

Copying James Vane's trades and holding each position for 1 Year would result in 56.25% of your transactions generating a profit, with an average return of -2.20% per trade.

2 Years

xxx

Success Rate

24/48 ratings generated profit

Average Return

-4.53%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -4.53% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1FME Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 1FME has received 2 Buy Ratings, 8 Hold Ratings, and 11 Sell Ratings. 1FME average Analyst price target in the past 3 months is 42.20.

Each month's total comprises the sum of three months' worth of ratings.

1FME Financial Forecast

1FME Earnings Forecast

Currently, no earnings data available.

1FME Sales Forecast

Currently, no sales data available.

1FME Stock Forecast FAQ

What is IT:1FME’s average 12-month price target, according to analysts?

Based on analyst ratings, Fresenius Medical Care AG & Co. KGaA’s 12-month average price target is 42.20.

What is IT:1FME’s upside potential, based on the analysts’ average price target?

Fresenius Medical Care AG & Co. KGaA has 6.03% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Fresenius Medical Care AG & Co. KGaA a Buy, Sell or Hold?

Fresenius Medical Care AG & Co. KGaA has a consensus rating of Hold, which is based on 2 buy ratings, 5 hold ratings and 5 sell ratings.

What is Fresenius Medical Care AG & Co. KGaA’s share price target?

The average share price target for Fresenius Medical Care AG & Co. KGaA is 42.20. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €60.00 ,and the lowest forecast is €32.00. The average share price target represents 6.03% Increase from the current price of €39.8.

What do analysts say about Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of Fresenius Medical Care AG & Co. KGaA?

To buy shares of IT:1FME, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Fresenius Medical Care AG & Co. KGaA (1FME) Stock Forecast & Price Target

1FME Analyst Ratings

1FME Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Fresenius Medical Care AG & Co. KGaA

1FME Analyst Recommendation Trends

1FME Financial Forecast

1FME Earnings Forecast

1FME Sales Forecast

1FME Stock Forecast FAQ

Detailed List of Analyst Forecasts